What is the price target for NH stock?
9 analysts have analysed NH and the average price target is 61.2 USD. This implies a price increase of 4433.33% is expected in the next year compared to the current price of 1.35.
NANTHEALTH INC (NH) Forecast, Price Target & Analyst Ratings
NASDAQ:NH • US6301043054
Current stock price
1.35 USD
-1.18 (-46.64%)
At close:
1.3 USD
-0.05 (-3.7%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NANTHEALTH INC (NH).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$61.20
Upside
+ 4,433.33%
From current price of $1.35 to mean target of $61.20, Based on 9 analyst forecasts
Low
$60.60
Median
$61.20
High
$63.00
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for NH. The average price target is 61.2 USD. This implies a price increase of 4433.33% is expected in the next year compared to the current price of 1.35.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
NH was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NH.
In the previous month the buy percentage consensus was at a similar level.
NH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 2, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 73.17M -5.50% | 62.649M -14.38% | 67.002M 6.95% | |
| EBITDA YoY % growth | -8.77M -8.41% | -25.176M -187.07% | -35.335M -40.35% | |
| EBIT YoY % growth | -25.54M 16.12% | -40.899M -60.14% | -51.327M -25.50% | |
| Operating Margin | -34.91% | -65.28% | -76.61% | |
| EPS YoY % growth | -3.90 -4.00% | -5.55 -42.31% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NANTHEALTH INC / NH Forecast FAQ
When does NANTHEALTH INC (NH) report earnings?
NANTHEALTH INC (NH) will report earnings on 2023-08-02.
Can you provide the consensus rating for NANTHEALTH INC stock?
The consensus rating for NANTHEALTH INC (NH) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.